Search results for "IMPAIRMENT"

showing 10 items of 434 documents

Optic nerve decompression in trauma and tumor patients

1999

Optic nerve decompression is a procedure that is now receiving increasing clinical attention. However, there are currently no standardized treatment protocols in the therapy of traumatic or pressure insults to the nerve. The present retrospective study was designed to report our experience with microscopic endonasal transethmoid-sphenoid optic nerve decompression in 24 unilateral trauma cases and 11 unilateral skull base tumor patients. In general preoperative visual acuities in the trauma patients were worse than in the tumor patients. Following surgery, 9 of 11 tumor patients (82%) had at least some improvement of their vision, including 5 complete recoveries. In the group with traumatic …

AdultMaleMicrosurgerymedicine.medical_specialtygenetic structuresDecompressionEye diseasemedicine.medical_treatmentVisual impairmentVisual AcuityBlindnessSkull Base NeoplasmsPostoperative ComplicationsOptic Nerve DiseasesmedicineHumansCranial nerve diseaseOrbital FracturesCraniotomyAgedbusiness.industryNerve Compression SyndromesEndoscopyGeneral MedicineMiddle AgedDecompression Surgicalmedicine.diseaseSurgeryTreatment OutcomeOtorhinolaryngologyOtorhinolaryngologyOptic Nerve InjuriesOptic nerveFemaleNeurosurgerymedicine.symptombusinessEuropean Archives of Oto-Rhino-Laryngology
researchProduct

Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease.

2008

Background: Cognitive impairment is common in multiple sclerosis (MS) and adds significantly to the burden of the disease. The ability to predict future cognitive impairment from imaging obtained at disease onset has not been investigated. Methods: 62 patients imaged within 3 months of a clinically isolated syndrome were assessed neuropsychologically 7 years later. Baseline and periodic MRI measures of lesions, atrophy and normal-appearing white and grey matter were regressed against neuropsychological scores to explore the best predictors of cognitive outcome. Results: 28 patients had developed clinically definite MS at follow-up and a further nine met revised McDonald criteria for MS. Def…

AdultMalePathologymedicine.medical_specialtyPediatricsMagnetic Resonance SpectroscopyAdolescentGrey matterNeuropsychological TestsCerebral VentriclesWhite matterCohort StudiesDisability EvaluationAtrophyMultiple Sclerosis Relapsing-RemittingPredictive Value of TestsmedicineHumansProspective StudiesNeurologic ExaminationAspartic AcidClinically isolated syndromeMultiple sclerosisCognitive disorderNeuropsychologyBrainMcDonald criteriaDipeptidesMiddle Agedmedicine.diseaseCognitive impairment: multiple sclerosisMagnetic Resonance ImagingPsychiatry and Mental healthmedicine.anatomical_structureSurgeryFemaleNeurology (clinical)AtrophyPsychologyCognition DisordersInositolFollow-Up StudiesJournal of neurology, neurosurgery, and psychiatry
researchProduct

The association between diabetes and cataract among 42,469 community-dwelling adults in six low- and middle-income countries

2018

Background: Cataract is a major cause of visual impairment in people with diabetes, yet a paucity of data is available in low- and middle-income countries (LMICs) on this comorbidity. Thus we assessed the association between diabetes and cataract in 6 LMICs. Methods: Cross-sectional, community-based data from the Study on Global Ageing and Adult Health (SAGE) was analyzed (n = 42,469 aged ≥18 years). Five years information on self-reported diagnosis of cataract was collected. Three definitions for cataract were used: (a) Self-reported diagnosis and/or past 12-month symptoms; (b) Solely self-reported diagnosis; and (c) Surgical treatment for cataract in the past five years. Diabetes was base…

AdultMalePediatricsmedicine.medical_specialtyEndocrinology Diabetes and MetabolismVisual impairment030209 endocrinology & metabolismcataract diabetesLogistic regressionCataractDiabetes Complications03 medical and health sciences0302 clinical medicineEndocrinologyQuality of lifeDiabetes mellitusCommunity-basedInternal MedicinemedicineHumans030212 general & internal medicineSurgical treatmentPovertyLow- and middle-income countriesbusiness.industryDiabetesTreatment optionsGeneral Medicinemedicine.diseaseComorbidityCross-Sectional StudiesSocial ClassLow and middle income countriesQuality of LifeFemaleIndependent Livingmedicine.symptombusinessDiabetes Research and Clinical Practice
researchProduct

Prevalence and causes of blindness and low vision in the Casteldaccia Eye Study.

1994

In a population-based survey performed on the middle-aged and elderly population of Casteldaccia, Sicily, we found that the prevalence of blindness was 0.47% and the prevalence of low vision 1.22%. Unilateral blindness affected 2.81% of the population and unilateral low vision 4.12%. Visual impairment was much more frequently seen in subjects aged 70 years or more than in younger persons. The main cause of visual impairment was cataract, followed by amblyopia, which was responsible for many cases of unilateral low vision.

AdultMalePediatricsmedicine.medical_specialtygenetic structuresEye DiseasesEye diseasePopulationVisual impairmentVision LowBlindnessVision disorderCellular and Molecular NeurosciencePrevalenceMedicineHumanseducationAgededucation.field_of_studyBlindnessbusiness.industryPublic healthMiddle Agedmedicine.diseasehumanitieseye diseasesSensory SystemsLow visionOphthalmologyItalyEtiologyFemalemedicine.symptombusinessGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
researchProduct

WAIS-IV Performance in Patients With Schizophrenia.

2019

Wechsler Adult Intelligence Scale (WAIS) is one of the most widely used instruments to measure cognitive functioning. The aims of this study were 1) to obtain the cognitive profile of Spanish patients with schizophrenia on the WAIS-IV; 2) to compare their profile to the profile of a healthy control group; and 3) to compare the cognitive profile of patients with schizophrenia to the performance observed in two separate previous studies in Canada and China. A sample of 99 outpatients and 99 healthy control participants, matched on age, sex, and educational level, were measured using the WAIS-IV, including 10 core subtests, 4 indices, and 2 general intelligence scores, to obtain their cognitiv…

AdultMalebehavioral disciplines and activities03 medical and health sciences0302 clinical medicineHealthy controlmedicineHumansVerbal comprehensionIn patientCognitive DysfunctionCognitive skillCognitive impairmentWechsler ScalesWechsler Adult Intelligence ScaleCognitionMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthSchizophreniaSchizophreniaFemalePsychology030217 neurology & neurosurgeryClinical psychologyThe Journal of nervous and mental disease
researchProduct

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of th…

2013

ObjectiveTo assess the effects of subcutaneous (sc) interferon (IFN) -1a on cognition over 5 years in mildly disabled patients with relapsing-remitting multiple sclerosis (RRMS).MethodsPatients aged 18-50 years with RRMS (Expanded Disability Status Scale score ≤4.0) who had completed the 3-year COGIMUS study underwent standardized magnetic resonance imaging, neurological examination, and neuropsychological testing at years 4 and 5. Predictors of cognitive impairment at year 5 were identified using multivariate analysis.ResultsOf 331 patients who completed the 3-year COGIMUS study, 265 participated in the 2-year extension study, 201 of whom (75.8%; sc IFN β-1a three times weekly: 44 µg, n = …

AdultMalemedicine.medical_specialty5 year follow upMultiple SclerosisAdolescentScienceInjections SubcutaneousBrain damageYoung AdultInterferonRecurrenceInternal medicinemedicineHumansIn patientYoung adultCognitive impairmentSex CharacteristicsMultidisciplinarymedicine.diagnostic_testbusiness.industryMultiple sclerosisQRMultiple Sclerosis Subcutaneous interferon β-1a cognitive impairmentMagnetic resonance imagingInterferon-betamedicine.diseaseTreatment OutcomeImmunologyMedicineFemaleSettore MED/26 - Neurologiamedicine.symptomSafetybusinessCognition DisordersInterferon beta-1amedicine.drugResearch ArticleFollow-Up Studies
researchProduct

Cognitive impairment in Behçet's disease patients without overt neurological involvement

2003

We investigated the prevalence of cognitive impairment in patients with Behc¸et’s disease (BD) without overt neurological involvement. The influence of disease duration, disease activity, prednisone dosage, and anxiety and depression levels was evaluated. Twenty-six consecutive BD outpatients and 26 healthy controls matched for age, education and sex completed a comprehensive neuropsychological battery including tests of memory, visuospatial and constructional abilities, language, attention and psychomotor speed, non-verbal reasoning and executive functioning. The Hamilton scales for anxiety and depression were administered. Disease activity was assessed using the Behc¸et’s Disease Current …

AdultMalemedicine.medical_specialtyBehcet's diseaseNeuropsychological TestsNeuropsychologyPredictive Value of TestsPrednisoneInternal medicineOdds RatiomedicineCorticosteroidHumansAttentionDisease activityDepression (differential diagnoses)DemographyLanguagePsychiatric Status Rating ScalesPsychomotor learningVascular diseaseBehcet SyndromeCase-control studyNeuropsychologyVerbal Learningmedicine.diseaseCognitive impairmentMemory Short-TermNeurologyCase-Control StudiesPhysical therapyAnxietySettore MED/26 - NeurologiaFemaleNeurology (clinical)medicine.symptomCognition DisordersPsychologyBehcet’s diseasePsychomotor Performancemedicine.drugJournal of the Neurological Sciences
researchProduct

Functional impairment in bipolar II disorder: Is it as disabling as bipolar I?

2010

It is well established that patients with bipolar disorder experience functional impairment even in remission. Nevertheless, bipolar II disorder remains understudied because most investigations to date include only bipolar I patients or just a small sample of bipolar II patients, without explicitly comparing both subtypes of disorder. The main objective of the current report is to evaluate overall and multiple domains of functioning, specifically in bipolar II disorder compared to patients with bipolar I disorder and healthy subjects.233 subjects from 3 groups were compared: bipolar I patients (n=106), bipolar II patients (n=66) and healthy controls (n=61). Bipolar patients meeting criteria…

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar I disorderFunctional impairmentPersonality InventoryArgentinaYoung Mania Rating ScaleDisability EvaluationBipolar II disorderRating scaleInternal medicinemental disordersmedicineHumansBipolar disorderPsychiatryDepression (differential diagnoses)DepressionCognitionMiddle Agedmedicine.diseaseHospitalizationPsychiatry and Mental healthClinical PsychologyChronic DiseaseFemalesense organsCognition DisordersPsychologyJournal of Affective Disorders
researchProduct

Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis

2013

© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar disorderTrail Making TestReviewNeuropsychological TestsVerbal learning03 medical and health sciencesMental Processes0302 clinical medicineRisk FactorsmedicineMemory spanHumansMental CompetencyAffective SymptomsBipolar disorderAge of OnsetPsychiatryPsychiatric Status Rating ScalesPsychotropic DrugsNeuropsychologyConfounding Factors EpidemiologicMiddle Agedmedicine.disease030227 psychiatryAffectPsychiatry and Mental healthMoodCognitive impairmentSchizophreniaNeuropsychological testsFemaleVerbal memoryCognition DisordersPsychology030217 neurology & neurosurgeryClinical psychology
researchProduct

Teoría de la mente y funcionalidad en pacientes bipolares en remisión sintomática

2013

Introducción: Los déficits en la funcionalidad son comunes durante la remisión en el trastorno bipolar (TB). Adicionalmente, existe evidencia de alteraciones en la cognición social en remisión clínica. Estos déficits podrían contribuir a la disfunción observada en estos pacientes. Material y métodos: Doce pacientes bipolares en remisión sintomática (7 bipolares tipo i y 5 de tipo ii) y 12 individuos controles sin patología psiquiátrica completaron el Test de las Miradas y el Test de Faux Pas para evaluar teoría de la mente (ToM), y el Test Breve para la Evaluación de la Funcionalidad (FAST). Resultados: El desempeño de los pacientes bipolares en el aspecto cognitivo de la ToM se ubicó por d…

AdultMalemedicine.medical_specialtyFunctional impairmentBipolar DisorderEmotionsTheory of MindCIENCIAS SOCIALESCognitionSocial cognitionTheory of mindInternal medicinemedicineHumansIn patientBipolar disorderPsychiatryFuncionalidadPsychological TestsTrastorno bipolarOtras PsicologíaCognitionGeneral MedicineMiddle Agedmedicine.diseasePsicologíaTeoría de la menteTranquilizing AgentsCase-Control StudiesFaux pasFemaleRemisión sintomáticaPsychology
researchProduct